Halozyme Therapeutics HALO 2024 Corporate Presentation

Halozyme Therapeutics presents corporate strategy and financial outlook through 2028, with focus on ENHANZE drug delivery technology platform. The presentation covers expected growth, profitability targets, revenue diversification, and plans for platform expansion including a high-volume auto-injector and potential partnerships.